1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,148 | 0,196 | 04.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.03. | hVIVO PLC - AIM Rule 17 and Schedule 2(g) Update | 1 | RNS | ||
| 21.03. | hVIVO PLC - Notice of Results | 2 | RNS | ||
| 07.03. | hVIVO PLC - Director/PDMR Shareholding | 1 | RNS | ||
| 27.02. | hVIVO acquires biological material storage specialist Cryostore | 2 | Sharecast | ||
| 27.02. | hVIVO PLC - Acquisition of Cryostore for up to £3.2m | 2 | RNS | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 17.02. | IN BRIEF: hVIVO signs £2 million deal as aims to progress hMPV care | 3 | Alliance News | ||
| 17.02. | Hvivo signs £2m contract with new biopharma client | 2 | Sharecast | ||
| 17.02. | hVIVO PLC - £2m hMPV characterisation study contract | 1 | RNS | ||
| 05.02. | hVIVO reports positive results from Shionogi RSV trial | 8 | Sharecast | ||
| 05.02. | Shionogi's RSV antiviral shows promise in hVIVO trial | 4 | Investing.com | ||
| 05.02. | hVIVO PLC - Shionogi reports positive RSV trial results | 5 | RNS | ||
| 03.02. | hVIVO wins contract for RSV drug human trial for Inhalon Biopharma | 5 | Alliance News | ||
| 03.02. | hVIVO signs human challenge trial contract with Inhalon Biopharma | 2 | Sharecast | ||
| 03.02. | hVIVO PLC - RSV contract signed with Inhalon Biopharma | 1 | RNS | ||
| 29.01. | hVIVO eyes double-digit revenue rise, announces new acquisition | 1 | Alliance News | ||
| 29.01. | Hvivo acquires two clinical research units, FY revenues up 11.9pc | 3 | Sharecast | ||
| 29.01. | hVIVO expands with German units acquisition for €10m | 4 | Investing.com | ||
| 29.01. | hVIVO PLC - Acquisition: two Clinical Research Units from CRS | 1 | RNS | ||
| 29.01. | hVIVO PLC - Trading update | 1 | RNS | ||
| 27.01. | ILiAD Biotechnologies, LLC: ILiAD and hVIVO Sign LOI for Pivotal Phase 3 Trial of BPZE1 Pertussis Vaccine Following FDA Meeting | 228 | Business Wire | Trial anticipated for H2 2025 to evaluate most advanced next generation intranasal pertussis vaccine for whooping cough
ILiAD Biotechnologies, LLC, a biotech company developing BPZE1, the most... ► Artikel lesen |
Seite:
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,781 | +0,75 % | Plus Therapeutics files to sell 1.57B shares of common stock for holders | ||
| LIFEWARD | 1,470 | -6,37 % | Lifeward Ltd.: FDA Issues Clearance for ReWalk 7 Exoskeleton | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| JD HEALTH | 3,560 | -0,56 % | JD HEALTH (06618): GRANT OF SHARE AWARDS AND UPDATE ON PREVIOUS SHARE AWARD GRANTS | ||
| EKSO BIONICS | 0,355 | +0,28 % | Ekso Bionics Holdings Aktie: Beeindruckende Innovationskraft | Der Exoskelett-Hersteller verzeichnet im letzten Quartal 2024 Umsatzsteigerungen und Margenwachstum, kämpft jedoch mit Jahresrückgang bei hoher Aktienvolatilität. Ekso Bionics meldete für das vierte... ► Artikel lesen | |
| IMUNON | 0,860 | -2,27 % | Imunon files to sell 10M shares of common stock, warrants | ||
| ROCKWELL MEDICAL | 0,848 | -7,73 % | ROUNDUP/Aktien New York: Erneute Dow-Verluste - Nasdaq-Rally pausiert | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Anders als zuletzt wird der US-Leitindex dabei aber von den anderen US-Indizes... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 10,700 | -2,73 % | Stifel maintains Buy on Viridian Therapeutics, $41 target | ||
| SINTX TECHNOLOGIES | 2,010 | -19,60 % | Pre-market Movers: Sintx Technologies, Cycurion, OSR Holdings, ReShape Lifesciences, NewGenIvf Group | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.35 A.M. ET).In the Green Sintx Technologies, Inc. (SINT) is up over 87%... ► Artikel lesen | |
| AETHLON MEDICAL | 0,430 | -100,00 % | XFRA DIVERSE INSTRUMENTE: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCASTOR MARITIME... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | ||
| NEURONETICS | 3,250 | +0,93 % | Neuronetics: Evernorth Health Services, a Cigna Company, Expands NeuroStar TMS Coverage for Adolescents Struggling with Depression | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| SAVARIA | 10,200 | +0,99 % | Savaria Corporation: Savaria Presents its Fourth Quarter and 2024 Results | LAVAL, Québec, March 05, 2025 (GLOBE NEWSWIRE) -- Savaria Corporation ("Savaria") (TSX: SIS), one of the global leaders in the accessibility industry, is pleased to announce its results for fiscal... ► Artikel lesen | |
| IMAC HOLDINGS | 0,192 | -4,00 % | IMAC Holdings, Inc. - 8-K, Current Report |
Das Unternehmen HVIVO PLC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,146 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.
